Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marniza Saad

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Oncology Practice|May 22, 2019
Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent ActionNirmala Bhoo-Pathy, Chiu-Wan Ng, Gerard Chin-Chye Lim, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Prostate cancer management in Southeast Asian countries: a survey of clinical practice patternsEdmund Chiong, Marniza Saad, Agus Rizal A H Hamid, et al.
BJU International|January 3, 2025
Selective treatment de-escalation in advanced prostate cancer: have we come full circle?Bryan Chong, Marniza Saad, Tsung Wen Chong, et al.
European Urology Oncology|May 6, 2025
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE TrialKim N Chi, Elena Castro, Gert Attard, et al.
BJU International|July 19, 2018
Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017Edmund Chiong, Declan G Murphy, Hideyuki Akaza, et al.
Cureus|December 13, 2024
Antibody Response Following COVID-19 Vaccination in Malaysian Cancer Patients and Healthy IndividualsChin Vern Song, Ros Suzanna Ahmad Bustamam, Gan Gin Gin, et al.
Future Oncology (London, England)|March 31, 2025
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2023
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
JCO Precision Oncology|June 21, 2024
Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate CancerDaniel Ang, Johan Chan, Whee Sze Ong, et al.
BJU International|May 12, 2019
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017Marniza Saad, Adlinda Alip, Jasmine Lim, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Oncology Practice|May 22, 2019
Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent ActionNirmala Bhoo-Pathy, Chiu-Wan Ng, Gerard Chin-Chye Lim, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Prostate cancer management in Southeast Asian countries: a survey of clinical practice patternsEdmund Chiong, Marniza Saad, Agus Rizal A H Hamid, et al.
BJU International|January 3, 2025
Selective treatment de-escalation in advanced prostate cancer: have we come full circle?Bryan Chong, Marniza Saad, Tsung Wen Chong, et al.
European Urology Oncology|May 6, 2025
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE TrialKim N Chi, Elena Castro, Gert Attard, et al.
BJU International|July 19, 2018
Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017Edmund Chiong, Declan G Murphy, Hideyuki Akaza, et al.
Cureus|December 13, 2024
Antibody Response Following COVID-19 Vaccination in Malaysian Cancer Patients and Healthy IndividualsChin Vern Song, Ros Suzanna Ahmad Bustamam, Gan Gin Gin, et al.
Future Oncology (London, England)|March 31, 2025
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2023
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.
JCO Precision Oncology|June 21, 2024
Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate CancerDaniel Ang, Johan Chan, Whee Sze Ong, et al.
BJU International|May 12, 2019
Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017Marniza Saad, Adlinda Alip, Jasmine Lim, et al.
Pageof 5